Trials / Conditions / Acute Leukemias of Ambiguous Lineage

Acute Leukemias of Ambiguous Lineage

5 registered clinical trials studyying Acute Leukemias of Ambiguous Lineage.

Status	Trial	Sponsor	Phase
Completed	S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acu NCT01925131	SWOG Cancer Research Network	Phase 1
Completed	Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoin NCT01371656	Children's Oncology Group	Phase 3
Completed	MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia NCT01231919	National Cancer Institute (NCI)	Phase 1
Completed	Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute NCT01132573	National Cancer Institute (NCI)	Phase 1
Terminated	Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating NCT00933985	National Cancer Institute (NCI)	Phase 1